Product Information
HYDROCHLOROTHIAZIDE 12.5 MG TB is a generic product labeled by Chartwell RX LLC, priced at $0.0404 per EA under NDC 62135073890. Its NADAC has been published 139 times since Nov 1, 2023.
Strength
12.5 mg/1
Manufacturer
Chartwell RX LLCNDC
62135073890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA085182On Market Since
5/2/2023
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has been published 139 times since Nov 1, 2023, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0404 per EA |
|---|---|
| All-time high | $0.0514 (Feb 14, 2024) |
| All-time low | $0.0345 (Nov 20, 2024) |
| 52-week high | $0.0458 |
| 52-week low | $0.0403 |
| Median price | $0.0436 |
| Average price | $0.0446 |
| Largest weekly change | -28.3% (Nov 20, 2024) |
| Weeks tracked | 139 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 30% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG TB, manufactured by Chartwell RX LLC, is $0.0404 per EA (NDC 62135073890), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG TB changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has declined 16.6%. It has been tracked across 139 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG TB?
Since Nov 1, 2023, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has ranged from a low of $0.0345 (Nov 20, 2024) to a high of $0.0514 (Feb 14, 2024), with a median of $0.0436 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG TB?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCHLOROTHIAZIDE 12.5 MG CP, is $0.0284 per EA — about 30% below HYDROCHLOROTHIAZIDE 12.5 MG TB.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG TB?
HYDROCHLOROTHIAZIDE 12.5 MG TB (NDC 62135073890) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification